TIPS Versus Portacaval Shunt for Acute Bleeding Varices in Cirrhosis

University of California, San Diego153 enrolled

Overview

In unselected cirrhotic patients with acute portal hypertension-related bleeding to compare the effectiveness in control of bleeding, mortality rate, duration of life, quality of life, and economic costs of two widely used treatment measures: (1) emergency transjugular intrahepatic portal-systemic shunt (TIPS), and (2) emergency portacaval shunt.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

153

Conditions

Bleeding

Interventions

Emergency portacaval shuntPROCEDURE

Emergency TIPSOTHER

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * All patients with UGI bleeding who are shown to have the findings of cirrhosis and esophagogastric varices or portal hypertensive gastropathy and require 2 or more units of blood transfusion will be included. Exclusion Criteria: * None

Locations (1)

UCSD Medical Center

San Diego, California, United States

Outcomes

Primary Outcomes

Survival

Time frame: 10 years

Secondary Outcomes

Control of bleeding and quality of life

Time frame: 10 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.